Pharmaceuticals

12:30pm

Fri August 24, 2012
Shots - Health Blog

Failure Of Lilly Drug Is Latest Alzheimer's Setback

Originally published on Fri August 24, 2012 1:19 pm

A PET scan of the brain of a person with Alzheimer's disease.
U.S. National Institute on Aging Wikimedia Commons

An experimental drug that aimed to slow the development of plaques and help clear them from the brains of Alzheimer's patients failed in two late-stage studies conducted by Eli Lilly & Co., the company said today.

Read more

2:45pm

Wed August 15, 2012
Shots - Health Blog

Safety Flag Raised For Codeine In Kids

When it comes to pain relief for kids, there may be better options than codeine.
iStockphoto.com

The Food and Drug Administration has warned doctors to be careful with codeine to relieve children's pain.

The agency noted reports of three kids who died and one who almost did after taking codeine following surgery. The kids had their tonsils or adenoids removed to treat obstructive sleep apnea.

Read more

2:36pm

Tue August 7, 2012
Shots - Health Blog

Scientists See Progress In Alzheimer's Despite Growing List of Drug Failures

A PET scan of the brain of a person with Alzheimer's disease.
U.S. National Institute on Aging via Wikimedia Commons

Another once-promising Alzheimer's drug has just been tossed on the pharmaceutical scrap heap.

This time it's a drug called bapineuzumab. Like several previous experimental drugs, it was designed to attack the plaques that build up in the brains of people with Alzheimer's.

And like those earlier drugs, it failed.

Read more

7:42am

Thu August 2, 2012
Shots - Health Blog

Mixed Feelings About Side Effects From Cholesterol Pills

Lipitor and other cholesterol-fighting drugs carry risks of side effects.
Paul Sakuma AP

Drugs to lower cholesterol run neck and neck with antidepressants for popularity in the U.S.

There's ample evidence cholesterol-lowering pills called statins can reduce the risk of a repeat heart attack. The pills are frequently prescribed for people who've never had a heart attack or stroke, but are at high risk for trouble.

Read more
Tags: 

4:20am

Sat July 28, 2012
Shots - Health Blog

New Funds Could Shorten Waiting Lists For AIDS Drugs

Originally published on Sat July 28, 2012 9:07 am

The pharmacy at Atlanta's Ponce de Leon Center stocks medications for 5,200 HIV/AIDS patients. Workers there aren't sure how much an increase in federal aid will help cut Georgia's waiting list for a HIV drug-assistance program.
Jim Burress WABE, Atlanta

The Obama administration last week announced nearly $80 million in grants to increase access to AIDS care across the United States. But will the money be enough to eliminate waiting lists for the AIDS Drug Assistance Program?

Advocates aren't sure. The program, known as ADAP, provides a safety net for people with HIV who have no means of paying for the drugs they need to fight the virus.

Read more

Pages